A Phase II Randomized Double-Blind Placebo-Controlled Multi-Center Dose Ranging Study of Intravenous Davlizumab in Patients With Moderate to Severe Ulcerative Colitis

  • De Villiers, Willem (PI)

Grants and Contracts Details

StatusFinished
Effective start/end date4/1/0312/31/04